cagrisema cagrilintide semaglutide phase 3 results 2024 2025 Novo Nordisk's 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026 CagriSema: Novo Nordisk's Next Weight

Laboratory-grade research material

By: Lindsay Hughes Principal, Applied Patient Experience Solutions, Patient Centered Solutions, IQVIA Part 2 of a Three-Part Series on Unlocking AIs Role in Modern Clinical Trials As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust

High-purity NNMT research compound for metabolic & cellular studies

B12 Vitamin Store Needle and Syringe Information The B12 Vitamin Store does not sell needles and syringes

BPC-157 (Body Protection Compound-157) is commonly described as a stable gastric pentadecapeptide: a 15-amino acid peptide linked in published literature to compounds associated with human gastric juice